170 related articles for article (PubMed ID: 16675660)
1. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
[TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.
Liekens S; Balzarini J; Hernández AI; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):975-80. PubMed ID: 17065049
[TBL] [Abstract][Full Text] [Related]
3. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
Liekens S; Hernández AI; Ribatti D; De Clercq E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
J Biol Chem; 2004 Jul; 279(28):29598-605. PubMed ID: 15123637
[TBL] [Abstract][Full Text] [Related]
4. 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
Casanova E; Hernandez AI; Priego EM; Liekens S; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
J Med Chem; 2006 Sep; 49(18):5562-70. PubMed ID: 16942029
[TBL] [Abstract][Full Text] [Related]
5. The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
Liekens S; Bronckaers A; Belleri M; Bugatti A; Sienaert R; Ribatti D; Nico B; Gigante A; Casanova E; Opdenakker G; Pérez-Pérez MJ; Balzarini J; Presta M
Mol Cancer Ther; 2012 Apr; 11(4):817-29. PubMed ID: 22302099
[TBL] [Abstract][Full Text] [Related]
6. Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59).
Bronckaers A; Aguado L; Negri A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ; Gago F; Liekens S
Biochem Pharmacol; 2009 Aug; 78(3):231-40. PubMed ID: 19389384
[TBL] [Abstract][Full Text] [Related]
7. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
Miszczak-Zaborska E; Smolarek M; Bartkowiak J
Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
[TBL] [Abstract][Full Text] [Related]
8. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of N3-substituted thymine acyclic nucleoside phosphonates and a comparison of their inhibitory effect towards thymidine phosphorylase.
Pomeisl K; Holý A; Votruba I; Pohl R
Bioorg Med Chem Lett; 2008 Feb; 18(4):1364-7. PubMed ID: 18221873
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phoshorylase as a target for antiangiogenesis treatment.
Peters GJ; Bijnsdorp IV; Fukushima M
Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537
[TBL] [Abstract][Full Text] [Related]
12. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
Balzarini J; Degrève B; Esteban-Gamboa A; Esnouf R; De Clercq E; Engelborghs Y; Camarasa MJ; Pérez-Pérez MJ
FEBS Lett; 2000 Oct; 483(2-3):181-5. PubMed ID: 11042277
[TBL] [Abstract][Full Text] [Related]
14. Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.
Diab SA; De Schutter C; Muzard M; Plantier-Royon R; Pfund E; Lequeux T
J Med Chem; 2012 Mar; 55(6):2758-68. PubMed ID: 22372816
[TBL] [Abstract][Full Text] [Related]
15. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
17. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
19. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
20. 7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.
Balzarini J; Gamboa AE; Esnouf R; Liekens S; Neyts J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
FEBS Lett; 1998 Oct; 438(1-2):91-5. PubMed ID: 9821965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
